1. Visco A, Priore G. Postmenopausal bartholin gland enlargement: a hospital-based cancer risk assessment. Obstet Gynecol [Internet]. 1996 Feb [cited 2023 Mar 2];87(2):286–90. Available from: http://linkinghub.elsevier.com/retrieve/pii/0029784495004041.
2. Turetta C, Mazzeo R, Capalbo G, Miano S, Fruscio R, Di Donato V, et al. Management of primary and recurrent Bartholin’s gland carcinoma: A systematic review on behalf of MITO Rare Cancer Group. Tumori J [Internet]. 2023 Nov 13 [cited 2024 Feb 2];03008916231208308. Available from: https://doi.org/10.1177/03008916231208308.
3. Ouldamer L, Chraibi Z, Arbion F, Barillot I, Body G. Bartholin’s gland carcinoma: Epidemiology and therapeutic management. Surg Oncol [Internet]. 2013 Jun 1 [cited 2023 Mar 2];22(2):117–22. Available from: https://www.sciencedirect.com/science/article/pii/S0960740413000224.
4. Bhalwal AB, Nick AM, Dos Reis R, Chen CL, Munsell MF, Ramalingam P, et al. Carcinoma of the Bartholin Gland: A Review of 33 Cases. Int J Gynecol Cancer [Internet]. 2016 May [cited 2023 Oct 30];26(4):785–9. Available from: https://ijgc.bmj.com/lookup/doi/10.1097/IGC.0000000000000656.
5. Oonk MHM, Planchamp F, Baldwin P, Mahner S, Mirza MR, Fischerová D, et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023. Int J Gynecol Cancer [Internet]. 2023 Jun 27 [cited 2023 Oct 27];ijgc. Available from: https://ijgc.bmj.com/content/early/2023/06/27/ijgc-2023-004486.